Fatty Liver Disease Nearly Doubles Mortality Risk
Source: Medscape
Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care to reduce excess mortality, researchers said.
TOPLINE:
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) face significantly higher risks of dying from nearly all major causes, with the most pronounced relative risks observed for hepatocellular carcinoma (HCC) and liv… [3107 chars]